INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 46h ago
House PTR6h ago
SEC 13F6h ago
Robinhood Chain6h ago

Most active filers · 30d

  1. 01Kurtz George0B / 239S · 10 late239 trades$59.22M
  2. 02SPSaba Capital Management, L.P.68B / 23S · 14 late91 trades$30.01M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  6. 06SJSheena Jonathan0B / 43S43 trades$3.14M
  7. 07CFCheng Chi Fung0B / 42S42 trades$15.33M
  8. 08RJRubinstein Julie0B / 37S37 trades$6.25M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Form 4 transactions

19,215 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
19
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$30K
315 sh
Jan 29, 2026Feb 2, 2026
Page 349 of 481
← PrevNext →

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 99 insiders$642K
  4. SELL
traded Jan 29, 2026
+4d
SEC Form 4

Evidence

19
FK
Feeley KevinCHIEF FINANCIAL OFFICER
WGSGeneDx Holdings Corp.
Open-market sale
SELL$184
2 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

18
QW
Quartel Adrian WChief Medical Officer
ZVRAZEVRA THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$40K
4,533 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

18
DA
Dandekar AtulCSBO
MAZEMaze Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$52K
1,200 sh
Jan 29, 2026Feb 2, 2026
traded Jan 29, 2026
+4dSEC Form 4

Evidence

14
SJ
Schafer JoshuaCCO
ZVRAZEVRA THERAPEUTICS, INC.
Open-market sale · 10b5-1 plan
SELL$30K
3,375 sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

0
WC
Wren ChrisVP of Operations
PLNHPlanet 13 Holdings Inc.
Open-market sale · 10b5-1 plan
SELL$4,365
25.0K sh
Jan 30, 2026Feb 2, 2026
traded Jan 30, 2026
+3dSEC Form 4

Evidence

56
BJ
Baker JeffPrincipal Accounting Officer
CRWVCoreWeave, Inc.
Open-market sale
SELL$534K
5,143 sh
Jan 29, 2026Jan 30, 2026
traded Jan 29, 2026
+1dSEC Form 4

Evidence

48
LN
Lantz Erin NChief Revenue Officer
LIFEEthos Technologies Inc.
Open-market sale
SELL$2.91M
162.7K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

48
SV
Sharma VipulChief Technology Officer
LIFEEthos Technologies Inc.
Open-market sale
SELL$3.57M
200.0K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

45
TK
Terence E. Adderley Revocable Trust K10% Owner
KELYBKELLY SERVICES INC
Open-market sale
SELL$106.00M
3.04M sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

44
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$2.31M
21.9K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

40
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.12M
10.7K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

39
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$179K
13.7K sh
Nov 11, 2025Jan 30, 2026
traded Nov 11, 2025
+80dSEC Form 4

Evidence

38
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$83K
728 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

38
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$59K
3,588 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

38
KW
Kucharski Brandt WalterChief Accounting Officer
LIFEEthos Technologies Inc.
Open-market sale
SELL$222K
12.4K sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

38
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$255K
21.5K sh
Nov 14, 2025Jan 30, 2026
traded Nov 14, 2025
+77dSEC Form 4

Evidence

38
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$80K
4,797 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

37
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$586K
5,511 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

37
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$252K
2,304 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

37
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$322K
2,974 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

35
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$230K
19.0K sh
Nov 17, 2025Jan 30, 2026
traded Nov 17, 2025
+74dSEC Form 4

Evidence

35
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$68K
6,000 sh
Nov 18, 2025Jan 30, 2026
traded Nov 18, 2025
+73dSEC Form 4

Evidence

35
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$89K
8,000 sh
Nov 19, 2025Jan 30, 2026
traded Nov 19, 2025
+72dSEC Form 4

Evidence

34
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$114K
1,031 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

34
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$106K
949 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

34
RC
Ring ChristineChief Legal Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$72K
4,333 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

33
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$1.22M
83.0K sh
Jan 12, 2026Jan 30, 2026
traded Jan 12, 2026
+18dSEC Form 4

Evidence

33
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$1.40M
96.9K sh
Jan 15, 2026Jan 30, 2026
traded Jan 15, 2026
+15dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$220K
22.0K sh
Dec 9, 2025Jan 30, 2026
traded Dec 9, 2025
+52dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$223K
22.0K sh
Dec 4, 2025Jan 30, 2026
traded Dec 4, 2025
+57dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$104K
10.0K sh
Nov 25, 2025Jan 30, 2026
traded Nov 25, 2025
+66dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$161K
17.2K sh
Dec 3, 2025Jan 30, 2026
traded Dec 3, 2025
+58dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$81K
8,760 sh
Dec 2, 2025Jan 30, 2026
traded Dec 2, 2025
+59dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$23K
2,061 sh
Nov 20, 2025Jan 30, 2026
traded Nov 20, 2025
+71dSEC Form 4

Evidence

32
SH
Stanley Hills LLC10% Owner
VWAVVisionWave Holdings, Inc.
Open-market sale
SELL$122K
12.0K sh
Nov 24, 2025Jan 30, 2026
traded Nov 24, 2025
+67dSEC Form 4

Evidence

32
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$1.50M
14.2K sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

31
VH
van Houte HansChief Financial Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$1,268
73 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

31
IN
Intrator Michael NDirector, CEO and President, 10% Owner
CRWVCoreWeave, Inc.
Open-market sale · 10b5-1 plan
SELL$34K
303 sh
Jan 28, 2026Jan 30, 2026
traded Jan 28, 2026
+2dSEC Form 4

Evidence

31
HG
Hansen GwennChief Scientific Officer
NRIXNurix Therapeutics, Inc.
Open-market sale
SELL$1,702
98 sh
Jan 30, 2026Jan 30, 2026
traded Jan 30, 2026
+0dSEC Form 4

Evidence

FERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 16
7 insiders$7.38M
  • SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  • BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  • SELLADUSAddus HomeCare CorpNov 6 – Nov 96 insiders$16.28M
  • SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K